AstraZeneca’s COVID-19 Vaccine Has Strong Response in Older Adults

On Thursday, the vaccine that AstraZeneca and Oxford University are producing showed a robust immune response in older adults.

The data published in the Lancet Medical Journal suggests that those that are over 70 years of age could potentially build robust immunity.

Maheshi Ramasamy, a consultant and co-lead investigator at the Oxford Vaccine Group, said, “The robust antibody and T-cell responses seen in older people in our study are encouraging.”